Literature DB >> 17957482

Beta-amyloid enhances intracellular calcium rises mediated by repeated activation of intracellular calcium stores and nicotinic receptors in acutely dissociated rat basal forebrain neurons.

James H Chin1, Frederick W Tse, Kim Harris, Jack H Jhamandas.   

Abstract

Beta-amyloid, a 39-43 amino acid peptide, may exert its biological effects via neuronal nicotinic acetylcholine receptors. Using the ratiometric dye, fura-2, we examined the effect of soluble beta-amyloid(1-42) on the concentration of intracellular Ca(2+) ([Ca(2+)](i)) in acutely dissociated rat basal forebrain neurons. Focal applications of nicotine (0.5-20 mM), evoked dose-dependent increases in intracellular [Ca(2+)](i) that were mediated by the entry of extracellular Ca(2+) via nicotinic acetylcholine receptors, and the release of intracellular Ca(2+) from stores. With repeated nicotine challenges, the nicotinic responses were potentiated by 98 +/- 12% (P < 0.05) while beta-amyloid(1-42)(100 nM) was present for approximately 5 min. This potentiation became larger during the subsequent washout of beta-amyloid(1-42), which was associated with a gradual rise in baseline [Ca(2+)](i). Application of beta-amyloid(1-42)by itself did not alter [Ca(2+)](i), and beta-amyloid(1-42)also had no significant effect on the response to repeated KCl challenges. Therefore, beta-amyloid(1-42) caused neither gross disturbance of cellular Ca(2+) homeostasis nor enhancement of voltage-gated Ca(2+) channels. Interestingly, beta-amyloid(1-42) transiently potentiated the response to repeated caffeine challenges, which was also associated with a transient rise in baseline [Ca(2+)](i). beta-amyloid(1-42) potentiation of nicotine-evoked rises in [Ca(2+)](i) was reversed by the SERCA pump inhibitor, thapsigargin, and the mitochondrial Na(+)/Ca(2+) exchanger inhibitor, CGP-37157. These results suggest that the dysregulation of [Ca(2+)](i) by beta-amyloid(1-42) during multiple challenges with nicotine or caffeine involved the sensitization or overfilling of intracellular stores that are maintained by SERCA pump and Ca(2+) efflux from the mitochondria.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17957482     DOI: 10.1007/s11068-007-9010-7

Source DB:  PubMed          Journal:  Brain Cell Biol        ISSN: 1559-7105


  8 in total

1.  Single-cell screening of cytosolic [Ca(2+)] reveals cell-selective action by the Alzheimer's Aβ peptide ion channel.

Authors:  Hopi Lin; Nelson J Arispe
Journal:  Cell Stress Chaperones       Date:  2014-11-01       Impact factor: 3.667

Review 2.  Molecular identity and functional properties of the mitochondrial Na+/Ca2+ exchanger.

Authors:  Raz Palty; Michal Hershfinkel; Israel Sekler
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

Review 3.  Mitochondrial permeability transition pore is a potential drug target for neurodegeneration.

Authors:  Valasani Koteswara Rao; Emily A Carlson; Shirley Shidu Yan
Journal:  Biochim Biophys Acta       Date:  2013-09-18

4.  Prolonged Abeta treatment leads to impairment in the ability of primary cortical neurons to maintain K+ and Ca2+ homeostasis.

Authors:  Lana Shabala; Claire Howells; Adrian K West; Roger S Chung
Journal:  Mol Neurodegener       Date:  2010-08-13       Impact factor: 14.195

Review 5.  Mitochondrial permeability transition pore in Alzheimer's disease: cyclophilin D and amyloid beta.

Authors:  Heng Du; Shirley ShiDu Yan
Journal:  Biochim Biophys Acta       Date:  2009-07-16

Review 6.  Unlocking the Door to Neuronal Woes in Alzheimer's Disease: Aβ and Mitochondrial Permeability Transition Pore.

Authors:  Heng Du; Shirley ShiDu Yan
Journal:  Pharmaceuticals (Basel)       Date:  2010-06-14

Review 7.  Mitochondria and aging: A role for the mitochondrial transition pore?

Authors:  Mathieu Panel; Bijan Ghaleh; Didier Morin
Journal:  Aging Cell       Date:  2018-06-11       Impact factor: 9.304

Review 8.  Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease.

Authors:  Simona Magi; Pasqualina Castaldo; Maria Loredana Macrì; Marta Maiolino; Alessandra Matteucci; Guendalina Bastioli; Santo Gratteri; Salvatore Amoroso; Vincenzo Lariccia
Journal:  Biomed Res Int       Date:  2016-06-02       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.